Advertisement
Advertisement
OGN
Organon & Co.
13.75
USDSponsored
+0.01
+0.07%
Aug 21, 15:58 UTC -4
Closed
After-Market
13.62
-0.13
-0.94%
OGN Earnings Reports
Positive Surprise Ratio
OGN beat 15 of 22 last estimates.
68%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.59B
/$0.94
Implied change from Q2 26 (Revenue/ EPS)
+1.77%
/+10.59%
Implied change from Q3 25 (Revenue/ EPS)
-1.02%
/-6.93%
Organon & Co. earnings per share and revenue
On Jul 31, 2026, OGN reported earnings of 0.85 USD per share (EPS) for Q2 26, missing the estimate of 0.92 USD, resulting in a -8.34% surprise. Revenue reached 1.56 billion, compared to an expected 1.58 billion, with a -1.50% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 0.94 USD, with revenue projected to reach 1.59 billion USD, implying an increase of 10.59% EPS, and increase of 1.77% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Auna S.A.
Report Date
Aug 18, 2026 For Q2 26
Estimate
$0.87
Actual
$0.50
Surprise
-42.39%
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.11
Actual
$0.10
Surprise
-16.11%
Forward Industries, Inc. Common Stock
Report Date
Aug 12, 2026 For Q3 26
Estimate
$0.03
Actual
$0.00
Surprise
-100.00%
Park Dental Partners, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.33
Actual
$0.66
Surprise
+96.08%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.18
Surprise
-13.85%
DocGo Inc. Common Stock
Report Date
Aug 17, 2026 For Q2 26
Estimate
-$0.06
Actual
$0.16
Surprise
+353.16%
SRX Global Inc
Report Date
Aug 13, 2026 For Q3 26
Estimate
-Actual
-$0.36
Surprise
-
Lifeward Ltd. Ordinary Shares
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$1.36
Actual
-$1.46
Surprise
-6.82%
NeuroOne Medical Technologies Corporation Common Stock
Report Date
Aug 13, 2026 For Q3 26
Estimate
-$0.22
Actual
-$0.28
Surprise
-26.70%
SeaStar Medical Holding Corporation Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.97
Actual
-$0.91
Surprise
+7.11%
FAQ
What were Organon & Co.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Organon & Co. reported EPS of $0.85, missing estimates by -8.34%, and revenue of $1.56B, -1.5% below expectations.
How did the market react to Organon & Co.'s Q2 2026 earnings?
The stock price moved -- 0%, changed from $13.55 before the earnings release to $13.55 the day after.
When is Organon & Co. expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Organon & Co.'s next earnings report?
Based on 4
analysts, Organon & Co. is expected to report EPS of $0.94 and revenue of $1.59B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement